1.
2.
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
(feeds.nature.com)
3.
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
(feeds.nature.com)
Today's top topics:
apple
openai
anthropic
iphone 18 pro
iphone duo
google
ios 27
ai safety
apple watch series 12
iphone